Join BIOHIT HealthCare on the 14th of May 2025 for a live free webinar discussing Peptest®, our innovative non-invasive diagnostic tool for reflux. The session will be delivered by Dr Andrew Woodcock, Chief Scientific Officer at RD Biomed, who will be offering expert insights into the test’s development, clinical utility and impact on modern reflux management.
Peptest uses lateral flow technology to detect pepsin in saliva samples, providing a fast and reliable method for identifying reflux-related conditions without the need for invasive procedures. The upcoming webinar will explore how this breakthrough test enhances diagnosis and supports better outcomes across both primary and specialist care settings.
Whether you are an ENT specialist, speech and language therapist, or a clinician involved in reflux management, this is an excellent opportunity to connect with the BIOHIT team and discover how Peptest is enhancing reflux diagnosis.
